Cambridge Investment Research Advisors
CCAP icon

Cambridge Investment Research Advisors’s Crescent Capital BDC CCAP Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CCAP Stock Details CCAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$238K Buy
21,787
+3,769
+21% +$46K ﹤0.01% 3658
2026
Q1 		$219K Buy
18,018
+2,590
+17% +$35.4K ﹤0.01% 3591
2025
Q4 		$217K Sell
15,428
-408
-3% -$5.8K ﹤0.01% 3508
2025
Q3 		$226K Buy
+15,836
New +$237K ﹤0.01% 3373

Other funds holding CCAP

TCDRS
Texas County & District Retirement System Austin, Texas $54.6M AUM 22.55% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $3.16B AUM 17.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.95B AUM 25.88% 1-Year Est. Return
AM
Ares Management Los Angeles, California $2.29B AUM 0.27% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
CC
CF Capital Cohasset, Massachusetts $83.4M AUM 16.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

Cambridge Investment Research Advisors's CCAP Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Crescent Capital BDC (CCAP) stake by 21% in Q2 2026, buying an estimated $46K and bringing the position to 21,787 shares worth $238K. The position accounts for ﹤0.01% of the portfolio, ranked #3658.

Cambridge Investment Research Advisors first reported a position in CCAP in Q3 2025 and has held it in 4 quarters since. 85 funds tracked by Wall St. Rank hold CCAP as of Q2 2026.

  • Cambridge Investment Research Advisors held 21,787 shares of Crescent Capital BDC worth $238K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 3,769 Crescent Capital BDC shares in Q2 2026, an estimated $46K.
  • Crescent Capital BDC made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3658 holding.
  • Cambridge Investment Research Advisors first reported a position in Crescent Capital BDC in Q3 2025 and has held it in 4 quarters since.
  • 85 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.